(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

DERIVADOS DE INDOL MACROCÍCLICOS COMO INIBIDORES DE MCL-1

ArquivadaInvention PatentPCT · EP2020082900
Talk to an expert

Application data

Number

112022009142

Type

Invention Patent

Filing

11/20/2020

Publication

07/26/2022

PCT

EP2020082900
View on INPI

Progress at the INPI

  1. Filing11/20/20
  2. Publication07/26/22
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 05/26/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

JANSSEN PHARMACEUTICA NV

BE

See this company's full portfolio

Inventors

B. B. (pessoa física)

BE

F. R. (pessoa física)

BE

Technical data

IPC Classification

A61K 31/395A61P 35/00C07D 515/22

Priority claims

EP

19210710.0 · 11/21/2019

Abstract

DERIVADOS DE INDOL MACROCÍCLICOS COMO INIBIDORES DE MCL-1. A presente invenção refere-se a agentes farmacêuticos úteis para terapia e/ou profilaxia em um indivíduo, composição farmacêutica compreendendo tais compostos e ao seu uso como inibidores da MCL-1, úteis para tratar doenças como o câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

05/26/2026

RPI 2890

Parecer de pré-exame

#6.23

01/06/2026

RPI 2870

Notificação de entrada na fase nacional - PCT

#1.3

07/26/2022

RPI 2690

Alteração de dados cadastrais

#1.1

05/24/2022

RPI 2681

Related

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.